| Journal: | Arquivos de neuro-psiquiatria |
| Database: | PERIÓDICA |
| System number: | 000419153 |
| ISSN: | 0004-282X |
| Authors: | Dutra, Livia Almeida1 Abrantes, Fabiano1 Toso, Fabio Fieni1 Pedroso, Jose Luiz1 Barsottini, Orlando Graziani Povoas1 Hoftberger, Romana2 |
| Institutions: | 1Universidade Federal de Sao Paulo, Divisao de Neurologia Geral, Sao Paulo. Brasil 2Medical University of Vienna, Institute of Neurology, Viena. Austria |
| Year: | 2018 |
| Season: | Ene |
| Volumen: | 76 |
| Number: | 1 |
| Pages: | 41-49 |
| Country: | Brasil |
| Language: | Inglés |
| Document type: | Artículo |
| Approach: | Analítico |
| English abstract | Autoimmune encephalitis (AIE) is one of the most common causes of noninfectious encephalitis. It can be triggered by tumors, infections, or it may be cryptogenic. The neurological manifestations can be either acute or subacute and usually develop within six weeks. There are a variety of clinical manifestations including behavioral and psychiatric symptoms, autonomic disturbances, movement disorders, and seizures. We reviewed common forms of AIE and discuss their diagnostic approach and treatment |
| Portuguese abstract | As encefalites autoimunes (EAI) são a principal causa de encefalite não-infecciosa. As manifestações neurológicas são variadas, incluindo alterações comportamentais ou psiquiátricas, disautonomia, transtornos do movimento e epilepsia. Habitualmente a instalação dos sintomas ocorre em até 6 semanas, de forma aguda ou subaguda. As EAI podem ser desencadeadas por tumores, quadros infecciosos virais ou ainda apresentar etiologia criptogênica. Este artigo revisa as principais EAI, estratégias de diagnóstico e tratamento |
| Disciplines: | Medicina |
| Keyword: | Neurología, Terapéutica y rehabilitación, Diagnóstico diferencial, Encefalitis autoinmune, Anticuerpos, Neoplasias, Status epilepticus, N-metil-D-aspartato, Receptores, Inmunoglobulinas, Rituximab |
| Keyword: | Neurology, Therapeutics and rehabilitation, Differential diagnosis, Autoimmune encephalitis, Neoplasms, Antibodies, Status epilepticus, N-methyl-D-aspartate, Receptors, Immunoglobulins, Rituximab |
| Full text: | Texto completo (Ver HTML) |
